Spanish Fly for two - how they affect libido in women and men
Contents Biologically active additive based on an extract obtained from a beetle with a fly (or fly...
Phosphalugel is an antacid drug that also has an enveloping and adsorbing effect..
The composition of the drug includes the active substance - aluminum phosphate.
Phosphalugel neutralizes free hydrochloric acid in the stomach, and also reduces the activity of pepsin. Within 10 minutes, the drug reduces the acidity to a level of 3.5-5. At the same time, the antacid effect of Phosphalugel is not associated with alkalization of gastric juice, and secondary hypersecretion of HCl does not occur.
The drug is not able to be absorbed in the gastrointestinal tract. Due to the adsorbing effect, when Phosphalugel is used, bacteria, gases, toxins, and viruses are removed from the gastrointestinal tract. Also characteristic is the normalization of the passage of the contents of the gastrointestinal tract when taking Phosphalugel.
The instructions for Phosphalugel indicate the following indications for use:
According to the instructions, Phosphalugel is contraindicated in:
According to strict indications, Phosphalugel can be prescribed in childhood (up to 12 years) and old age.
When taking this drug, a number of side effects may develop, which cause negative feedback about Phosphalugel from patients. The following side effects have been registered: vomiting, nausea, constipation, changes in taste, allergic reactions. To prevent the development of side effects, it is necessary to use Phosphalugel only as prescribed by a doctor and follow the dosage regimen.
With prolonged use of Phosphalugel at a high dosage, hypocalcemia, hypophosphatemia, hypercalciuria, osteoporosis, osteomalacia, hyperaluminemia, nephrocalcinosis, encephalopathy may develop.
Phosphalugel overdose symptoms - constipation. Treatment is the use of laxatives.
When using the drug for more than two weeks, the development of a chronic overdose (Newcastle bone disease) is possible. Symptoms: hypophosphatemia (myasthenia gravis, malaise, osteoporosis, osteomalacia); kidney failure; aluminum encephalopathy (apraxia, dysarthria, dementia, convulsions).
Phosphalugel is intended for oral administration. The drug can be used in pure form or diluted in water.
A single dosage of Phosphalugel is 1-2 sachets (1 sachet contains 8.8 g of active ingredient). The frequency of admission is two to three times a day. In case of poisoning, burns with caustic drugs, the dosage is 3-5 sachets at a time.
With reflux esophagitis, ulcerative lesions of the gastrointestinal tract, Phosphalugel is taken at bedtime or two hours after a meal, with pain - immediately. With diaphragmatic hernia, the drug is recommended to be taken immediately after meals, as well as at bedtime, with enterocolitis - before meals twice a day, with colopathy - before breakfast and at bedtime.
The duration of Phosphalugel therapy is determined by the doctor based on the symptoms of the disease.
According to the indications, Phosphalugel can be used in pediatrics in the following dosages: at the age of up to 6 months - 4 g or a teaspoon after each feeding (6 times); after 6 months - 8g or 2 teaspoons after each feeding (4 times).
Phosphalugel is able to reduce or slow down the absorption of indomethacin, digoxin, salicylates, phenytoin, chlorpromazine, antihistamines, diflunisal, beta-blockers, isoniazid, azithromycin, tetracyclines, cefpodoxime, rifampicin, barbiturates, indirect anticoagulants, ursodeoxycholic and chenodez hydroxycholic acid, lansoprazole, penicillamine. M anticholinergics lengthen and enhance the action of Phosphalugel and analogues.
If it is necessary to use Phosphalugel for a long time, it is necessary to ensure a sufficient level of phosphate intake in the body.
With an unspecified diagnosis, long-term use of Phosphalugel is not recommended.
According to the indications, Phosphalugel can be prescribed to patients with diabetes mellitus, since the drug does not contain sugar.
Phosphalugel can be prescribed together with cimetidine, disopyramide, ketoprofen, amoxicillin, prednisolone.
Taking Phosphalugel does not affect the X-ray data.
There are no reliable data on the safety of using the drug during pregnancy and lactation. According to clinical studies, according to strict indications, Phosphalugel can be used occasionally during pregnancy and lactation.
The drug is available in the form of a 20% oral gel in sachets containing 2.08 and 2.48 g of the active ingredient.
The contents of the sachet must be thoroughly kneaded between the fingers before use.
Pharmacological effect - antacid, enveloping, adsorbing.
At a temperature of 15-25 °C.
Keep out of the reach of children.
Do not use after the expiry date stated on the packaging.
in a box of 20 or 26 pcs.
in a box of 20 or 26 pcs.
White or almost white homogeneous gel, sweet taste, with a taste and smell of orange.
It has an acid-neutralizing, enveloping, adsorbing effect. Reduces the proteolytic activity of pepsin. Does not cause alkalization of gastric juice, keeping the acidity of gastric contents at the physiological level. Does not lead to secondary hypersecretion of hydrochloric acid.
Forms a protective layer on the mucous membrane of the gastrointestinal tract.
Promotes the removal of toxins, gases and microorganisms throughout the digestive tract, normalizes the passage of contents through the intestines.
For adults:
peptic ulcer of the stomach and duodenum;
gastritis with normal or increased secretory function;
diaphragmatic hernia;
reflux esophagitis;
non-ulcer dyspepsia syndrome;
functional diarrhea;
gastric and intestinal disorders caused by intoxication, taking medications, irritants (acids, alkalis), alcohol.
For children:
esophagitis;
gastroesophageal reflux;
peptic ulcer of the stomach and duodenum.
hypersensitivity to the drug;
severe renal dysfunction.
It is possible to use during pregnancy and during breastfeeding according to indications, in therapeutic doses.
Constipation (rare, mainly in the elderly and bedridden patients).
inside, can be in pure form or diluted in half a glass of water before taking. Adults and children over 6 years old - 1-2 packs. 2-3 times a day; with gastroesophageal reflux, diaphragmatic hernia - immediately after meals and at night; with peptic ulcer of the stomach and duodenum - 1-2 hours after eating and immediately if pain occurs; with gastritis and dyspepsia - before meals; with functional diseases of the colon - in the morning on an empty stomach and at night. The drug is repeated if pain occurs in the intervals between doses.
Children: up to 6 months - 4 g (1/4 pack or 1 teaspoon) after each of 6 feedings; after 6 months - 8 g (1/2 pack or 2 teaspoons) after each of 4 feedings.
Symptoms: inhibition of gastrointestinal motility (due to the large amount of aluminum ions).
Treatment: prescription of laxatives.
Do not take the drug for a long time without a doctor's prescription. Use with caution in the presence of kidney disease, liver cirrhosis, severe heart failure. In elderly patients and patients with impaired renal function, when using Phosphalugel at recommended doses, an increase in the concentration of aluminum in the blood serum is possible.
Antibiotics of the tetracycline group, iron preparations, cardiac glycosides should be taken no earlier than 2 hours after taking Phosphalugel.
It is possible to use the drug in therapeutic doses during periods of pregnancy and lactation according to indications.
With constipation, which occasionally occurs when taking Phosphalugel, it is recommended to increase the amount of daily water consumed.
The drug can be used by patients suffering from diabetes; prophylactically to reduce the absorption of radioactive elements.
The use of Phosphalugel does not affect the results of x-ray examination.
When using Phosphalugel simultaneously with other drugs, you should consult your doctor, since Phosphalugel reduces the effectiveness of some drugs.
Keep out of the reach of children.
Do not use after the expiry date stated on the packaging.
Category ICD-10 | Synonyms of diseases according to ICD-10 |
---|---|
A05.9 Bacterial food poisoning, unspecified | Bacterial intoxications |
Diarrhea due to food intoxication | |
Acute diarrhea due to food poisoning | |
food intoxication | |
food poisoning | |
Food poisoning | |
food poisoning | |
Food poisoning | |
food poisoning | |
Toxic diarrhea | |
K21 Gastroesophageal reflux | Biliary reflux esophagitis |
Gastroesophageal reflux disease | |
Gastrocardiac syndrome | |
Gastroesophageal reflux disease | |
Gastroesophageal reflux | |
non-erosive reflux disease | |
Syndrome gastrocardiac | |
Roemheld syndrome | |
Erosive reflux esophagitis | |
Ulcerative reflux esophagitis | |
K25 Gastric ulcer | Helicobacter pylori |
Pain syndrome in gastric ulcer | |
Inflammation of the stomach lining | |
Inflammation of the gastrointestinal mucosa | |
benign stomach ulcer | |
Exacerbation of gastroduodenitis on the background of peptic ulcer | |
Exacerbation of peptic ulcer | |
Exacerbation of gastric ulcer | |
Organic gastrointestinal disease | |
Postoperative gastric ulcer | |
Ulcer recurrence | |
Symptomatic stomach ulcers | |
Helicobacteriosis | |
Chronic inflammatory disease of the upper gastrointestinal tract associated with Helicobacter pylori | |
Erosive and ulcerative lesions of the stomach | |
Erosive lesions of the stomach | |
Erosion of the gastric mucosa | |
peptic ulcer | |
Stomach ulcer | |
Ulcerative lesion of the stomach | |
Ulcerative lesions of the stomach | |
K26 Duodenal ulcer | Pain syndrome in duodenal ulcer |
Pain syndrome in peptic ulcer of the stomach and duodenum | |
Disease of the stomach and duodenum associated with Helicobacter pylori | |
Exacerbation of peptic ulcer | |
Exacerbation of duodenal ulcer | |
Peptic ulcer of the stomach and duodenum | |
Recurrent duodenal ulcer | |
Symptomatic ulcers of the stomach and duodenum | |
Helicobacteriosis | |
Helicobacter pylori eradication | |
Erosive and ulcerative lesions of the duodenum | |
Erosive and ulcerative lesions of the duodenum associated with Helicobacter pylori | |
Erosive lesions of the duodenum | |
Peptic ulcer of the duodenum | |
Ulcerative lesions of the duodenum | |
K29.6.1* Hyperacid gastritis | Pain in acute gastritis with high acidity |
Gastritis with high acidity | |
Gastritis with increased secretory function | |
Gastritis chronic hypersecretory | |
Hyperacid gastritis | |
Hyperacid gastritis | |
K30 Dyspepsia | Fermentative dyspepsia |
Hyperacid dyspepsia | |
Putrid dyspepsia | |
Dyspepsia | |
Dyspepsia | |
Dyspepsia of nervous origin | |
Dyspepsia of pregnant women | |
Dyspepsia fermentation | |
Dyspepsia putrefactive | |
Dyspepsia drug | |
Dyspepsia due to gastrointestinal disease | |
Dyspepsia due to GI dysmotility | |
Dyspepsia due to unusual food or overeating | |
Dyspeptic phenomena during pregnancy | |
Dyspeptic syndrome | |
Dyspeptic disorder | |
gastric dyspepsia | |
Delayed gastric emptying | |
slow digestion | |
Idiopathic dyspepsia | |
acid dyspepsia | |
Upper GI dysmotility | |
Indigestion | |
Nervous dyspepsia | |
Non-ulcer dyspepsia | |
Feeling of heaviness in the stomach after eating | |
Postprandial functional dyspepsia | |
Fermentation processes in the intestines | |
Stomach disorders | |
Gastrointestinal disorders | |
Disorders of the digestive process | |
Disorders from the gastrointestinal tract | |
Stomach upset | |
indigestion | |
Indigestion in infants | |
Symptoms of dyspepsia | |
Syndrome of putrefactive dyspepsia | |
Syndrome of putrefactive dyspepsia in young children | |
Digestive insufficiency syndrome | |
Non-Ulcer Dyspepsia Syndrome | |
Toxic dyspepsia | |
functional dyspepsia | |
Functional digestive disorders | |
chronic dyspepsia | |
Chronic episodes of dyspepsia | |
Essential dyspepsia | |
K31.8.2* Hyperacidity of gastric juice | Hyperacid dyspepsia |
hyperacid state | |
Hyperacid states | |
Hyperacidosis | |
Hypersecretion of gastric juice | |
Pathological hypersecretion | |
Acidity | |
Increased acidity of the stomach | |
Increased secretion of gastric juice | |
Increased acid production | |
K44 Diaphragmatic hernia | Diaphragmatic hernia |
hiatal hernia | |
Hiatal hernia | |
K59.1 Functional diarrhea | diarrheal syndrome |
Diarrhea | |
Diarrhea of non-infectious origin | |
Diarrhea after gastrectomy | |
Diarrhea with long-term enteral feeding through a tube | |
Diarrhea with electrolyte imbalance | |
Diarrhea in children | |
prolonged diarrhea | |
Nonspecific diarrhea | |
Acute diarrhea | |
Persistent diarrhea | |
Diarrhea | |
Diarrhea (diarrhea) | |
diarrhea syndrome | |
functional diarrhea | |
chronic diarrhea | |
Chronic diarrhea | |
Enterocolitis of non-infectious origin | |
T50.9 Other and unspecified drugs, medicaments and biological substances | Correction of side effects of drugs |
drug intoxication | |
Drug intoxication | |
Acute drug poisoning | |
Acute drug poisoning | |
Acute poisoning with potent and toxic substances | |
Drug poisoning | |
Oxalate poisoning | |
Poisoning with iodine preparations | |
Poisoning by caustic liquids | |
Poisoning with potent and toxic substances | |
T51 Toxic effect of alcohol | Alcohol intoxication |
alcohol intoxication | |
Alcohol intoxication | |
Acute alcohol intoxication | |
Chronic alcohol intoxication | |
Y57.9 Adverse reactions in therapeutic use of drugs and medicaments, unspecified | Allergic drug reactions |
Allergic reactions to drugs | |
Allergic reactions to drugs | |
Allergic reactions to medications | |
Allergic reactions to drugs | |
Allergic reactions to radiopaque agents | |
Allergic reactions due to medication | |
drug allergy | |
Anaphylactic drug reactions | |
Anaphylactic reactions to drugs | |
Hepatotoxic substances | |
Hepatotoxic effect of drugs | |
Diarrhea medication | |
Idiosyncrasy to drugs | |
Idiosyncrasy toxic | |
drug addiction | |
drug leukopenia | |
medicinal fever | |
drug intolerance | |
Drug-induced liver injury | |
Drug-induced lung disease | |
Undesirable drug effects | |
Acute allergic reaction to drugs | |
Toxic reactions to drugs |
Aluminum phosphate (aluminum phosphate)
◊ Gel for oral administration white or almost white, homogeneous after mixing, with an orange smell.
Excipients: sorbitol solution 70% - 4.286 g, agar-agar 800 - 0.08 g, pectin - 0.1 g, calcium sulfate dihydrate - 0.01 g, potassium sorbate - 0.053 g, orange flavor - 0.032 g, purified water - up to 20 g.
20 g - sachets (sachets) multilayer heat-sealed (20) - packs of cardboard.
An antacid. Neutralizes hydrochloric acid of gastric juice and reduces the proteolytic activity of pepsin. It is practically not absorbed from the gastrointestinal tract and does not cause alkalosis. Being adsorbed on the gastric mucosa in the form of hydrophilic colloidal micelles, aluminum phosphate creates a protective mucoid layer that protects the mucosa from the effects of hydrochloric acid, pepsin, endogenous and exogenous toxic substances.
Does not cause phosphate deficiency in the body.
When taken orally, it has low absorption. Most of the aluminum phosphate is insoluble, a small part is precipitated in the intestine in the form of oxides and insoluble carbonates.
Peptic ulcer of the stomach and duodenum in the acute phase, chronic with increased and normal secretory function of the stomach in the acute phase, acute gastritis, acute duodenitis, symptomatic ulcers of various origins, erosion of the gastrointestinal mucosa, hiatal hernia, enterocolitis, sigmoiditis, proctitis, diverticulitis , diarrhea in patients after gastrectomy, dyspeptic phenomena (including neurotic genesis, after errors in diet, medication, chemotherapy), acute pancreatitis, chronic pancreatitis in the acute phase, poisoning and intoxication.
For the purpose of prevention to reduce the absorption of radioactive elements.
Individual. The dose is set depending on the dosage form used and indications.
From the digestive system:(especially in the elderly and bedridden patients), nausea, vomiting, changes in taste sensations.
From the side of laboratory indicators: with prolonged use in high doses - hypophosphatemia, hypocalcemia, increased levels of aluminum in the blood.
From the musculoskeletal system: osteomalacia, osteoporosis.
From the side of the central nervous system: encephalopathy.
From the urinary system: hypercalciuria, nephrocalcinosis, renal failure.
Aluminum preparations, which are used both, interact with most drugs for oral administration, both by changing the pH of gastric juice and rapid gastric emptying, and by adsorption to form complexes that are not absorbed.
With the simultaneous use of citrates, they increase the absorption of aluminum from the gastrointestinal tract.